Advertisement
Advertisement

ORGO

ORGO logo

Organogenesis Holdings Inc. Class A Common Stock

2.38
USD
Sponsored
-0.09
-3.64%
Jun 11, 16:00 UTC -4
Closed
exchange

After-Market

2.42

+0.04
+1.68%

ORGO Earnings Reports

Positive Surprise Ratio

ORGO beat 20 of 29 last estimates.

69%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$55.34M
/
-$0.26
Implied change from Q1 26 (Revenue/ EPS)
+48.64%
/
-36.59%
Implied change from Q2 25 (Revenue/ EPS)
-45.22%
/
+160.00%

Organogenesis Holdings Inc. Class A Common Stock earnings per share and revenue

On May 07, 2026, ORGO reported earnings of -0.41 USD per share (EPS) for Q1 26, missing the estimate of -0.31 USD, resulting in a -29.66% surprise. Revenue reached 37.23 million, compared to an expected 44.17 million, with a -15.71% difference. The market reacted with a -6.32% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 55.34 million USD, implying an decrease of -36.59% EPS, and increase of 48.64% in Revenue from the last quarter.
FAQ
For Q1 2026, Organogenesis Holdings Inc. Class A Common Stock reported EPS of -$0.41, missing estimates by -29.66%, and revenue of $37.23M, -15.71% below expectations.
The stock price moved down -6.32%, changed from $2.53 before the earnings release to $2.37 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 4 analysts, Organogenesis Holdings Inc. Class A Common Stock is expected to report EPS of -$0.26 and revenue of $55.34M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement